Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Hutson

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
BMJ Open|September 2, 2025
Mental health disorders among people living with HIV in sub-Saharan Africa: a scoping review protocolWaheed Adeola Adedeji, Adeyinka Ganiyat Ishola, Olufisayo Elugbadebo, et al.
JAMA Network Open|May 4, 2023
Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast CancerRikki A Cannioto, Kristopher M Attwood, Evan W Davis, et al.
Journal of the National Cancer Institute|March 11, 2024
Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndromeYurong Song, Holli Loomans-Kropp, Ryan N Baugher, et al.
Frontiers in Oncology|September 25, 2023
Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancerYurong Song, Travis D Kerr, Chelsea Sanders, et al.
Frontiers in Oncology|August 22, 2022
Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLCRachel Evans, Kelvin Lee, Paul K Wallace, et al.
Journal of the National Cancer Institute|April 3, 2020
Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With SurvivalRikki A Cannioto, Alan Hutson, Shruti Dighe, et al.
Journal for Immunotherapy of Cancer|June 20, 2020
Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancerAnanth Annapragada, Andrew Sikora, Catherine Bollard, et al.
Research Square|February 23, 2026
Preferred evolutionary routes of convergence in Klebsiella pneumoniae favor siderophore acquisition over hypervirulenceFrancois Lebreton, Anjali Sapre, Melissa Martin, et al.
Journal for Immunotherapy of Cancer|October 26, 2024
Ten challenges and opportunities in computational immuno-oncologyRiyue Bao, Alan Hutson, Anant Madabhushi, et al.
Cancer|February 14, 2022
Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 studyPallawi Torka, Othman S Akhtar, Nishitha M Reddy, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
BMJ Open|September 2, 2025
Mental health disorders among people living with HIV in sub-Saharan Africa: a scoping review protocolWaheed Adeola Adedeji, Adeyinka Ganiyat Ishola, Olufisayo Elugbadebo, et al.
JAMA Network Open|May 4, 2023
Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast CancerRikki A Cannioto, Kristopher M Attwood, Evan W Davis, et al.
Journal of the National Cancer Institute|March 11, 2024
Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndromeYurong Song, Holli Loomans-Kropp, Ryan N Baugher, et al.
Frontiers in Oncology|September 25, 2023
Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancerYurong Song, Travis D Kerr, Chelsea Sanders, et al.
Frontiers in Oncology|August 22, 2022
Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLCRachel Evans, Kelvin Lee, Paul K Wallace, et al.
Journal of the National Cancer Institute|April 3, 2020
Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With SurvivalRikki A Cannioto, Alan Hutson, Shruti Dighe, et al.
Journal for Immunotherapy of Cancer|June 20, 2020
Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancerAnanth Annapragada, Andrew Sikora, Catherine Bollard, et al.
Research Square|February 23, 2026
Preferred evolutionary routes of convergence in Klebsiella pneumoniae favor siderophore acquisition over hypervirulenceFrancois Lebreton, Anjali Sapre, Melissa Martin, et al.
Journal for Immunotherapy of Cancer|October 26, 2024
Ten challenges and opportunities in computational immuno-oncologyRiyue Bao, Alan Hutson, Anant Madabhushi, et al.
Cancer|February 14, 2022
Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 studyPallawi Torka, Othman S Akhtar, Nishitha M Reddy, et al.
Pageof 10